Reports Q4 revenue $17.5M, consensus $17.39M. “By successfully meeting our revised fiscal 2025 guidance, we have demonstrated Simulations Plus (SLP)’ resilience and agility in navigating evolving market dynamics,” said Shawn O’Connor, CEO of Simulations Plus. “We delivered 13% revenue growth and achieved 8% growth in both adjusted EBITDA and adjusted EPS. Looking ahead to fiscal 2026, we anticipate low single-digit revenue growth at the mid-point of the guidance range, assuming current market conditions remain. Importantly, we believe we are well-positioned to capture upside should the spending environment improve for our pharmaceutical and biotech clients.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLP:
- Strong Q4 Results and Promising 2026 Outlook Drive Buy Rating for Simulations Plus
- Simulations Plus Announces Fiscal 2025 Results and 2026 Guidance
- Simulations Plus sees FY26 adjusted EPS $1.03-$1.10, consensus 87c
- Simulations Plus management to meet with KeyBanc
- SLP Earnings this Week: How Will it Perform?